BMO ARK Genomic Revolution Fund (NEO:ARKG)
10.67
0.00 (0.00%)
Jul 30, 2025, 4:00 PM EDT
NEO:ARKG Holdings Information
NEO:ARKG is an equity ETF with a total of 33 individual holdings. The top holdings are Tempus AI stock at 9.37%, CRISPR Therapeutics AG at 8.34%, Twist Bioscience at 6.83%, Natera at 5.98%, and Guardant Health at 5.98%.
Total Holdings
33
Top 10 Percentage
58.81%
Asset Class
Equity
ETF Category
Theme
Assets
4.40M
PE Ratio
n/a
Sector Allocation
Top 25 Holdings
No. | Symbol | Name | % Weight |
---|---|---|---|
1 | TEM | Tempus AI, Inc. | 9.37% |
2 | CRSP | CRISPR Therapeutics AG | 8.34% |
3 | TWST | Twist Bioscience Corporation | 6.83% |
4 | NTRA | Natera, Inc. | 5.98% |
5 | GH | Guardant Health, Inc. | 5.98% |
6 | RXRX | Recursion Pharmaceuticals, Inc. | 5.34% |
7 | ADPT | Adaptive Biotechnologies Corporation | 4.78% |
8 | SDGR | Schrödinger, Inc. | 4.71% |
9 | CDNA | CareDx, Inc | 3.89% |
10 | PSNL | Personalis, Inc. | 3.58% |
11 | VCYT | Veracyte, Inc. | 3.46% |
12 | BEAM | Beam Therapeutics Inc. | 3.39% |
13 | TXG | 10x Genomics, Inc. | 3.36% |
14 | IONS | Ionis Pharmaceuticals, Inc. | 3.34% |
15 | ABSI | Absci Corporation | 2.80% |
16 | ARCT | Arcturus Therapeutics Holdings Inc. | 2.34% |
17 | NTLA | Intellia Therapeutics, Inc. | 2.21% |
18 | n/a | CASH | 1.96% |
19 | ILMN | Illumina, Inc. | 1.95% |
20 | NRIX | Nurix Therapeutics, Inc. | 1.83% |
21 | AMGN | Amgen Inc. | 1.82% |
22 | BFLY | Butterfly Network, Inc. | 1.68% |
23 | MASS | 908 Devices Inc. | 1.63% |
24 | VEEV | Veeva Systems Inc. | 1.52% |
25 | QSI | Quantum-Si incorporated | 1.46% |
As of May 30, 2025